טוען...
NEXT GENERATION ORAL PrEP: BEYOND TENOFOVIR
PURPOSE: Clinical trials of oral pre-exposure prophylaxis (PrEP) have focused testing on regimens of tenofovir (TDF) with or without emtricitabine (FTC). However, TDF may be associated with toxicities (renal, bone) and FTC may select for drug resistance. In this review, we discuss agents that might...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3732461/ https://ncbi.nlm.nih.gov/pubmed/23032733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COH.0b013e328358b9ce |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|